Home › Conditions › Alcohol Withdrawal Syndrome
Neurology
Alcohol Withdrawal Syndrome
Alcohol withdrawal begins 6–24 hours after last drink. Minor symptoms peak at 24–36h; seizures at 24–48h; delirium tremens (DTs) at 48–72h with peak mortality. Assess severity with CIWA-Ar score. All patients need thiamine to prevent Wernicke's encephalopathy.
CIWA-Ar / Chlordiazepoxide Protocol
The pathway
CIWA-Ar assessment
Score: nausea/vomiting, tremor, sweating, anxiety, agitation, perceptual disturbances, headache, clouding of sensorium. Mild ≤8, moderate 9–15, severe ≥16. Repeat 4-hourly minimum. Do not use CIWA-Ar in delirium — use clinical observations and RASS.
Wernicke's — prevention and treatment
- Lower risk: thiamine 50mg PO QDS
- High-risk inpatient, no Wernicke’s signs: 200–300mg IM or IV OD for 3–5 days, review daily; then oral thiamine
- Suspected Wernicke’s: 300–500mg IV TDS for 3–5 days, review daily. Still symptomatic after day 5: 300–500mg IV OD for a further 3–5 days, continuing while improving
- IM Pabrinex is discontinued. Prescribe thiamine in mg, checking the product strength and route
Chlordiazepoxide protocol (front-loading)
Seizure management
Alcohol withdrawal seizure: benzodiazepines (lorazepam 2–4mg IV) first-line. Do NOT use phenytoin (not effective for alcohol withdrawal seizures). Chlordiazepoxide regime may need increasing.
Delirium Tremens (DTs)
DTs: acute confusion + autonomic instability (tachycardia, hypertension, fever, sweating). ITU if severe. High-dose benzodiazepines IV. Monitor electrolytes (hyponatraemia, hypomagnesaemia, hypophosphataemia). Mortality 5–15% if untreated.
Monitoring & discharge
Repeat CIWA-Ar at least 4-hourly while receiving withdrawal medication, sooner if worsening; use RASS/clinical observations for DTs. U&E, LFTs, Mg, phosphate. BM monitoring. Seizure precautions (no driving, no heights). Alcohol withdrawal can last 7–10 days. AUDIT-C for alcohol use disorder assessment. Refer to alcohol specialist services / community detox.
Drugs
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Thiamine | Prophylaxis 200–300mg OD; Wernicke’s 300–500mg TDS | IM/IV prophylaxis; IV treatment | High risk includes malnutrition, decompensated liver disease or previous Wernicke’s. See regimen above; oral 50mg QDS for lower risk. Give parenteral doses where anaphylaxis treatment is available. Check/correct magnesium. Never delay emergency glucose for hypoglycaemia; give thiamine promptly. |
| Chlordiazepoxide | 10–40mg QDS + PRN 10–20mg | PO | Titrate to CIWA-Ar. Taper over 7 days. Avoid in liver failure (use lorazepam). |
| Lorazepam | 1–4mg | IV/IM | If cannot take oral, or active seizure. Short-acting benzodiazepine. |
| Haloperidol | 0.5–2mg | PO/IM | Adjunct for severe agitation in DTs. Does NOT treat withdrawal per se. |
When to escalate
- CIWA-Ar ≥16 or DTs — high-dependency environment
- Seizure — benzodiazepines IV, consider ITU
- Suspected Wernicke's (confusion, ataxia or abnormal eye movements) — thiamine 300–500mg IV TDS for 3–5 days, daily review and senior input
- Haemodynamic instability in DTs — ITU
Reference: NICE CG100 / UK Alcohol Treatment Guidelines ch16 / NHS SPS thiamine guidance
Practise and explore
Practise a case or explore differentials here on the website. The optional browser app adds personal learning tools and saved progress.